On the Road Back to Normalcy: Following Science Over Noise in SARS-CoV-2

por Shah, Sadia Z., Bryce, Alan H.
Publicado 2021

Hypoxia-Activated Alkylating Agents in BRCA1-Mutant Ovarian Serous Carcinoma

por Conroy, Michael, Borad, Mitesh J, Bryce, Alan H
Publicado 2017

Targeting TMPRSS2 in SARS-CoV-2 Infection

por Baughn, Linda B., Sharma, Neeraj, Elhaik, Eran, Sekulic, Aleksandar, Bryce, Alan H., Fonseca, Rafael
Publicado 2020

Clonal analyses of refractory testicular germ cell tumors

por Barrett, Michael T., Lenkiewicz, Elzbieta, Malasi, Smriti, Stanton, Melissa, Slack, James, Andrews, Paul, Pagliaro, Lance, Bryce, Alan H.
Publicado 2019

Evolving Natural History of Metastatic Prostate Cancer

por Nafissi, Nellie N, Kosiorek, Heidi E, Butterfield, Richard J, Moore, Cassandra, Ho, Thai, Singh, Parminder, Bryce, Alan H
Publicado 2020

Guidelines for Management of Treatment-Emergent Adverse Events During Rucaparib Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer

por Labadie, Brian W, Morris, David S, Bryce, Alan H, Given, Robert, Zhang, Jingsong, Abida, Wassim, Chowdhury, Simon, Patnaik, Akash
Publicado 2022

Phase I study of PT-112, a novel pyrophosphate-platinum immunogenic cell death inducer, in advanced solid tumours

por Karp, Daniel D., Camidge, D. Ross, Infante, Jeffery R., Ames, Tyler D., Price, Matthew R., Jimeno, José, Bryce, Alan H.
Publicado 2022

PANDA: pathway and annotation explorer for visualizing and interpreting gene-centric data

por Hart, Steven N., Moore, Raymond M., Zimmermann, Michael T., Oliver, Gavin R., Egan, Jan B., Bryce, Alan H., Kocher, Jean-Pierre A.
Publicado 2015

Performance of a Cell-Free DNA-Based Multi-cancer Detection Test in Individuals Presenting With Symptoms Suspicious for Cancers

por Bryce, Alan H., Thiel, David D., Seiden, Michael V., Richards, Donald, Luan, Ying, Coignet, Marie, Zhang, Quan, Zhang, Nan, Hubbell, Earl, Kurtzman, Kathryn N., Klein, Eric A.
Publicado 2023

Randomized, Open-Label Phase 2 Study of Apalutamide plus Androgen Deprivation Therapy versus Apalutamide Monotherapy versus Androgen Deprivation Monotherapy in Patients with Bioche...

por Aggarwal, Rahul, Alumkal, Joshi J., Szmulewitz, Russell Z., Higano, Celestia S., Bryce, Alan H., Lopez-Gitlitz, Angela, McCarthy, Sharon A., Miladinovic, Branko, McQuarrie, Kelly, Thomas, Shibu, Zhang, Ke, Small, Eric J.
Publicado 2022

Performing Automatic Identification and Staging of Urothelial Carcinoma in Bladder Cancer Patients Using a Hybrid Deep-Machine Learning Approach

por Sarkar, Suryadipto, Min, Kong, Ikram, Waleed, Tatton, Ryan W., Riaz, Irbaz B., Silva, Alvin C., Bryce, Alan H., Moore, Cassandra, Ho, Thai H., Sonpavde, Guru, Abdul-Muhsin, Haidar M., Singh, Parminder, Wu, Teresa
Publicado 2023

Clinical Outcomes of Stereotactic Radiosurgery-Related Radiation Necrosis in Patients with Intracranial Metastasis from Melanoma

por Thomson, Holly M, Fortin Ensign, Shannon P, Edmonds, Victoria S, Sharma, Akanksha, Butterfield, Richard J, Schild, Steven E, Ashman, Jonathan B, Zimmerman, Richard S, Patel, Naresh P, Bryce, Alan H, Vora, Sujay A, Sio, Terence T, Porter, Alyx B
Publicado 2023

Shared and unique genomic structural variants of different histological components within testicular germ cell tumours identified with mate pair sequencing

por Bryce, Alan H., Egan, Jan B., Smadbeck, James B., Johnson, Sarah H., Murphy, Stephen J., Harris, Faye R., Halling, Geoffrey C., Terra, Simone B. S. P., Cheville, John, Pagliaro, Lance, Leibovich, Brad, Costello, Brian A., Vasmatzis, George
Publicado 2019

Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer

por Velez, Miguel Gonzalez, Kosiorek, Heidi E., Egan, Jan B., McNatty, Andrea L., Riaz, Irbaz B., Hwang, Steven R., Stewart, Glenn A., Ho, Thai H., Moore, Cassandra N., Singh, Parminder, Sharpsten, Renee K., Costello, Brian A., Bryce, Alan H.
Publicado 2021

Biomarkers for Predicting Abiraterone Treatment Outcome and Selecting Alternative Therapies in Castration‐Resistant Prostate Cancer

por Qin, Sisi, Gao, Huanyao, Kim, Wootae, Zhang, Huan, Gu, Yayun, Kalari, Krishna R., Sinnwell, Jason P., Scholz, Jodi A., Xie, Fang, Yin, Ping, Yu, Jia, Qin, Bo, Zhuang, Yongxian, Wei, Lixuan, Tan, Winston, Bryce, Alan H., Weinshilboum, Richard M., Wang, Liewei
Publicado 2022

Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment

por Sicotte, Hugues, Kalari, Krishna R., Qin, Sisi, Dehm, Scott M., Bhargava, Vipul, Gormley, Michael, Tan, Winston, Sinnwell, Jason P., Hillman, David W., Li, Ying, Vedell, Peter T., Carlson, Rachel E., Bryce, Alan H., Jimenez, Raphael E., Weinshilboum, Richard M., Kohli, Manish, Wang, Liewei
Publicado 2022

A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona

por Ho, Thai H., Nateras, Rafael Nunez, Yan, Huihuang, Park, Jin G., Jensen, Sally, Borges, Chad, Lee, Jeong Heon, Champion, Mia D., Tibes, Raoul, Bryce, Alan H., Carballido, Estrella M., Todd, Mark A., Joseph, Richard W., Wong, William W., Parker, Alexander S., Stanton, Melissa L., Castle, Erik P.
Publicado 2015

Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer

por Hart, Steven N, Ellingson, Marissa S, Schahl, Kim, Vedell, Peter T, Carlson, Rachel E, Sinnwell, Jason P, Barman, Poulami, Sicotte, Hugues, Eckel-Passow, Jeanette E, Wang, Liguo, Kalari, Krishna R, Qin, Rui, Kruisselbrink, Teresa M, Jimenez, Rafael E, Bryce, Alan H, Tan, Winston, Weinshilboum, Richard, Wang, Liewei, Kohli, Manish
Publicado 2016

Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations

por DeLeon, Thomas T., Almquist, Daniel R., Kipp, Benjamin R., Langlais, Blake T., Mangold, Aaron, Winters, Jennifer L., Kosiorek, Heidi E., Joseph, Richard W., Dronca, Roxana S., Block, Matthew S., McWilliams, Robert R., Kottschade, Lisa A., Rumilla, Kandelaria M., Voss, Jesse S., Seetharam, Mahesh, Sekulic, Aleksandar, Markovic, Svetomir N., Bryce, Alan H.
Publicado 2020

A phase I/II study of rovalpituzumab tesirine in delta-like 3—expressing advanced solid tumors

por Mansfield, Aaron S., Hong, David S., Hann, Christine L., Farago, Anna F., Beltran, Himisha, Waqar, Saiama N., Hendifar, Andrew E., Anthony, Lowell B., Taylor, Matthew H., Bryce, Alan H., Tagawa, Scott T., Lewis, Karl, Niu, Jiaxin, Chung, Christine H., Cleary, James M., Rossi, Michael, Ludwig, Carrianne, Valenzuela, Ricardo, Luo, Yan, Aggarwal, Rahul
Publicado 2021